131 related articles for article (PubMed ID: 32983965)
21. A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinations.
Bordeaux ZA; Kwatra SG; Booth L; Dent P
Anticancer Drugs; 2023 Apr; 34(4):544-550. PubMed ID: 36847046
[TBL] [Abstract][Full Text] [Related]
22. Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells.
Booth L; Roberts JL; Cruickshanks N; Conley A; Durrant DE; Das A; Fisher PB; Kukreja RC; Grant S; Poklepovic A; Dent P
Mol Pharmacol; 2014 Mar; 85(3):408-19. PubMed ID: 24353313
[TBL] [Abstract][Full Text] [Related]
23. The multi-kinase inhibitor lenvatinib interacts with the HDAC inhibitor entinostat to kill liver cancer cells.
Roberts JL; Poklepovic A; Booth L; Dent P
Cell Signal; 2020 Jun; 70():109573. PubMed ID: 32087304
[TBL] [Abstract][Full Text] [Related]
24. Corrigendum: GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells
Booth L; West C; Von Hoff D; Dent P
Front Oncol; 2021; 11():677725. PubMed ID: 33937087
[TBL] [Abstract][Full Text] [Related]
25. Neratinib decreases pro-survival responses of [sorafenib + vorinostat] in pancreatic cancer.
Booth L; Poklepovic A; Dent P
Biochem Pharmacol; 2020 Aug; 178():114067. PubMed ID: 32504550
[TBL] [Abstract][Full Text] [Related]
26. The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib.
Booth L; Roberts JL; Poklepovic A; Dent P
Front Oncol; 2019; 9():650. PubMed ID: 31380285
[TBL] [Abstract][Full Text] [Related]
27. PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide.
Booth L; Roberts JL; Poklepovic A; Gordon S; Dent P
Oncotarget; 2017 Jan; 8(1):1449-1468. PubMed ID: 27903966
[TBL] [Abstract][Full Text] [Related]
28. Rationally Repurposing Ruxolitinib (Jakafi (®)) as a Solid Tumor Therapeutic.
Tavallai M; Booth L; Roberts JL; Poklepovic A; Dent P
Front Oncol; 2016; 6():142. PubMed ID: 27379204
[TBL] [Abstract][Full Text] [Related]
29. Neratinib augments the lethality of [regorafenib + sildenafil].
Booth L; Roberts JL; Rais R; Cutler RE; Diala I; Lalani AS; Hancock JF; Poklepovic A; Dent P
J Cell Physiol; 2019 Apr; 234(4):4874-4887. PubMed ID: 30203445
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of GZ17-6.02 resistance.
Booth L; West C; Von Hoff D; Dent P
Anticancer Drugs; 2022 Jun; 33(5):415-423. PubMed ID: 35276694
[TBL] [Abstract][Full Text] [Related]
31. Palbociclib augments Neratinib killing of tumor cells that is further enhanced by HDAC inhibition.
Booth L; Roberts JL; Rais R; Cutler RE; Diala I; Lalani AS; Poklepovic A; Dent P
Cancer Biol Ther; 2019; 20(2):157-168. PubMed ID: 30183517
[TBL] [Abstract][Full Text] [Related]
32. Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species.
Roberts JL; Poklepovic A; Booth L
Oncotarget; 2017 Nov; 8(59):99451-99469. PubMed ID: 29245915
[TBL] [Abstract][Full Text] [Related]
33. AR12 increases BAG3 expression which is essential for Tau and APP degradation via LC3-associated phagocytosis and macroautophagy.
Dent P; Booth L; Roberts JL; Poklepovic A; Martinez J; Cridebring D; Reiman EM
Aging (Albany NY); 2022 Oct; 14(20):8221-8242. PubMed ID: 36227739
[TBL] [Abstract][Full Text] [Related]
34. Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Booth L; Cruickshanks N; Tavallai S; Roberts JL; Peery M; Poklepovic A; Dent P
Cancer Biol Ther; 2014; 15(12):1646-57. PubMed ID: 25482938
[TBL] [Abstract][Full Text] [Related]
35. The levels of mutant K-RAS and mutant N-RAS are rapidly reduced in a Beclin1 / ATG5 -dependent fashion by the irreversible ERBB1/2/4 inhibitor neratinib.
Booth L; Roberts JL; Poklepovic A; Kirkwood J; Sander C; Avogadri-Connors F; Cutler RE; Lalani AS; Dent P
Cancer Biol Ther; 2018 Feb; 19(2):132-137. PubMed ID: 29219657
[TBL] [Abstract][Full Text] [Related]
36. Digitoxin Suppresses Human Cytomegalovirus Replication via Na
Mukhopadhyay R; Venkatadri R; Katsnelson J; Arav-Boger R
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321306
[TBL] [Abstract][Full Text] [Related]
37. NEDD4 over-expression regulates the afatinib resistant phenotype of NSCLC cells.
Booth L; Roberts JL; Poklepovic A; Dent P
Oncol Signal; 2018 Jun; 1(1):19-30. PubMed ID: 30740589
[TBL] [Abstract][Full Text] [Related]
38. HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody
Booth L; Roberts JL; Poklepovic A; Avogadri-Connors F; Cutler RE; Lalani AS; Dent P
Oncotarget; 2017 Oct; 8(52):90262-90277. PubMed ID: 29163826
[TBL] [Abstract][Full Text] [Related]
39. Tanshinone IIA Restores Dynamic Balance of Autophagosome/Autolysosome in Doxorubicin-Induced Cardiotoxicity via Targeting Beclin1/LAMP1.
Wang X; Li C; Wang Q; Li W; Guo D; Zhang X; Shao M; Chen X; Ma L; Zhang Q; Wang W; Wang Y
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31261758
[TBL] [Abstract][Full Text] [Related]
40. Abrus Agglutinin, a type II ribosome inactivating protein inhibits Akt/PH domain to induce endoplasmic reticulum stress mediated autophagy-dependent cell death.
Panda PK; Behera B; Meher BR; Das DN; Mukhopadhyay S; Sinha N; Naik PP; Roy B; Das J; Paul S; Maiti TK; Agarwal R; Bhutia SK
Mol Carcinog; 2017 Feb; 56(2):389-401. PubMed ID: 27182794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]